A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

计划入组 14 人 · 首次发布于 2019 年 8 月 28 日

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

计划入组 16 人 · 首次发布于 2024 年 11 月 12 日

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

计划入组 325 人 · 首次发布于 2013 年 1 月 11 日

Lysophosphatidic acid 1 receptor antagonists(Ajinomoto Co., Inc.)

1-Naphthoxyacetic acid

C₁₂H₁₀O₃

1-naphthaleneacetic acid

C₁₂H₁₀O₂

Arvinas Estrogen Receptor, Inc.

United States

NHI-1

United States

Arvinas Androgen Receptor, Inc.

United States

Chronic Lower Back Pain Pipeline Shows Mixed Results as Multiple Phase III Trials Report Outcomes

Amgen's Q3 2024 Revenue Jumps 23% Fueled by Rare Disease Portfolio

Novel Therapies Show Promise for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis Treatment